Continuous glucose monitoring replaces finger-prick testing with a small subcutaneous sensor that records interstitial glucose every 5 minutes, generating a dynamic 24-hour glucose profile. KG Hospital is among Tamil Nadu's highest-volume CGM centres with dedicated sensor initiation clinics, remote monitoring setup and structured ambulatory glucose profile (AGP) interpretation.
Types of Diabetes We Treat
KG Hospital manages the full spectrum of diabetes mellitus — from early-stage prediabetes and gestational diabetes to complex insulin-dependent Type 1 and advanced Type 2 disease with complications.
Autoimmune Insulin Deficiency
Immune-mediated destruction of pancreatic beta cells requiring lifelong insulin replacement. KG Hospital specialises in advanced CSII therapy and CGM-guided management.
- Insulin pump (CSII) initiation & optimisation
- Closed-loop / hybrid closed-loop therapy
- Paediatric & adolescent diabetes clinic
- Diabetic ketoacidosis (DKA) emergency care
Insulin Resistance & Relative Deficiency
The most prevalent form — driven by lifestyle, genetics and metabolic syndrome. Our intensive management includes modern non-insulin agents and structured reversal pathways.
- GLP-1 agonists, SGLT-2 inhibitors, DPP-4 inhibitors
- Basal-bolus insulin intensification
- Cardiovascular risk reduction
- Diabetes reversal for eligible patients
Pregnancy-Onset Glucose Intolerance
Glucose intolerance first recognised during pregnancy. KG Hospital's joint obstetric-diabetology clinic ensures safe glucose control for mother and baby.
- 75g OGTT screening at 24–28 weeks
- CGM for real-time gestational glucose tracking
- Insulin and metformin safety in pregnancy
- Postpartum T2D surveillance programme
Reversible High-Risk State
Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are highly reversible with structured intervention — we aim to prevent 100% of progressions.
- Intensive lifestyle intervention programme
- Pharmacological prevention when indicated
- Waist-hip ratio, HOMA-IR and metabolic panel
- 6-monthly HbA1c and OGTT surveillance
Treatments & Procedures
Our diabetes care team deploys the latest pharmacological and device-based therapies alongside structured nutrition, psychology and exercise medicine.
Patients using CGM reduce HbA1c by 0.5–1.5% compared to finger-prick testing alone, while reducing hypoglycaemic episodes by up to 40%. KG Hospital's CGM programme includes structured education on reading glucose trends, not just numbers.
Insulin therapy has evolved dramatically — ultra-long-acting basals (insulin degludec, glargine U300), ultra-rapid meal-time analogues (insulin aspart, lispro), and once-weekly basal insulins (insulin icodec) now enable highly personalised regimens. Our endocrinologists individualise therapy based on CGM data, lifestyle patterns and complication risk.
Modern diabetes pharmacotherapy goes beyond glucose lowering — GLP-1 receptor agonists reduce cardiovascular events and promote weight loss, while SGLT-2 inhibitors protect kidneys and reduce heart failure hospitalisation. Our team tailors therapy based on cardiovascular risk, kidney function, weight and patient preference.
- Among first 5 centres in Tamil Nadu to initiate tirzepatide in clinical practice (2023)
- KG Hospital SGLT-2 inhibitor prescribing audit published in JAPI (2022)
Insulin Pump Therapy (CSII)
KG Hospital operates Tamil Nadu's most experienced insulin pump programme — managing over 200 active pump patients with dedicated pump nurses, 24h helpline and structured initiation protocols.
KG Hospital initiated Tamil Nadu's first dedicated paediatric insulin pump programme in 2009. Our team has successfully transitioned over 150 children with Type 1 diabetes to CSII therapy, with 30% achieving TIR >70%.
Comparing Insulin Delivery Methods
| Parameter | Insulin Pump (CSII) | Multiple Daily Injections | Premixed Insulin |
|---|---|---|---|
| Dosing Flexibility | Maximum | High | Limited |
| HbA1c Reduction | 0.5–1.0% extra | Moderate | Variable |
| Hypoglycaemia Risk | Lowest | Moderate | Highest |
| Lifestyle Freedom | Excellent | Good | Restricted |
| Cost | Higher | Moderate | Lowest |
| Learning Curve | Training required | Moderate | Simple |
Diabetic Foot Clinic
KG Hospital's Diabetic Foot Clinic is one of the most comprehensive in Tamil Nadu — combining diabetology, vascular surgery, orthopaedics, podiatry and wound care to achieve a 98% limb salvage rate.
Thyroid & Hormonal Disorders
Beyond diabetes, our endocrinologists manage the full spectrum of hormonal diseases — thyroid, adrenal, pituitary, gonads and metabolic bone disease.
Thyroid disease is the second most common endocrine disorder after diabetes in India. KG Hospital offers comprehensive thyroid evaluation including high-resolution thyroid ultrasound, FNAC for nodules, radioactive iodine (RAI) uptake studies and biochemical monitoring. Graves' disease is managed medically, with surgical and RAI options coordinated with the endocrine surgery team.
PCOS affects 1 in 5 women in India and is the leading cause of female infertility and a major T2D risk factor. Our PCOS clinic combines endocrinology, gynaecology and nutrition to address insulin resistance, androgen excess, cycle irregularity and fertility concerns.
Rare but serious endocrine conditions including Cushing's syndrome, primary adrenal insufficiency (Addison's), acromegaly and pituitary adenomas require subspecialty expertise. KG Hospital's endocrinologists work closely with neurosurgery, urology and oncology for multidisciplinary management.
Diabetes Reversal Programme
KG Hospital's structured Diabetes Reversal Programme is based on the Counterpoint / DiRECT trial methodology — combining intensive caloric restriction, medical nutrition therapy, supervised exercise and metabolic monitoring to achieve drug-free remission in eligible Type 2 diabetes patients.
Patients with Type 2 diabetes diagnosed within the past 6 years, BMI >27 kg/m², no severe diabetic complications, motivated for lifestyle change, and not on insulin for more than 12 months may qualify for our reversal programme assessment.
Programme Pathway
Diabetes Risk Assessment
Know your risk. Annual screening is recommended for anyone over 35 in India — earlier if you have risk factors below.
Your Patient Journey
From your first consultation through to long-term diabetes management, here's how we care for you.